The U.S. gynecological devices market is expected reach a market value of $1.3 Billion by 2029 as technological advancements, shifting demographics, and changing healthcare practices shape its landscape. This blog post will delve into the key trends, market dynamics, and major competitors that drive this evolving industry.
U.S. Gynecological Devices Market Overview
The U.S. gynecological device market encompasses various segments, including assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters.
Price competition has intensified in recent years as providers seek alternative solutions, prompting sellers to offer competitive pricing to secure broader market access. The advent of purchasing groups and the growing elderly population’s demand for gynecological procedures have further influenced market dynamics.
The US is witnessing a demographic shift with a rapidly growing elderly population. In 2022, over 54 million individuals were aged 65 or older, constituting more than 16% of the population. By 2026, this demographic is projected to surpass 16% and reach 20% by 2050. Additionally, positive birth rates and a net migration rate contribute to a projected population rise of nearly 25 million over the forecast period.
With age, the need for gynecological procedures typically increases. As a result, the total market for gynecological devices is poised for substantial growth. Healthcare providers must be prepared to cater to this expanding demographic and adapt their practices to meet the increasing demand for gynecological services.
Major Competitors
In the competitive US gynecological device market, several companies have emerged as dominant players. Hologic, Medtronic, Cooper Surgical, and Minerva Surgical collectively account for over 50% of the market share. Hologic holds the top position, primarily due to its products in the global endometrial ablation, hysteroscopic morcellators for mechanical uterine tissue removal, endoscopes, and fluid management device markets. Their commitment to innovation and technological excellence has enabled them to maintain a strong foothold in the market. Medtronic, the second-leading competitor, competes in the morcellator and fluid management device markets. Its TruClear™ Hysteroscopic morcellator has garnered significant market share in the United States, contributing to the company’s overall success. Cooper Surgical, a prominent competitor, leads in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments. Their strong presence in these areas has contributed to their third-leading market share in the US gynecological device market.
Conclusion
As the market continues to evolve, it is crucial for all stakeholders to embrace innovation, foster strategic collaborations, and prioritize patient-centric approaches to drive advancements in gynecological devices and ultimately improve women’s healthcare outcomes.
To learn more about the U.S. Gynecological Device Market, check out our full 2023 report suite below and request your own complimentary executive summary!
